Interactions in Man of Delta-9-tetrahydrocannabinol. II. Cannabinol and Cannabidiol

Overview

Journal Clin Pharmacol Ther

Publisher Wiley

Specialty Pharmacology

Date 1975 Jul 1

PMID 1097148

Citations 29

Authors

L E Hollister

H Gillespie

Affiliations

Soon will be listed here.

Abstract

Oral doses of delta-9-tetrahydrocannabinol (THC) 20 mg, combined with placebo or with 40 mg dses of cannabinol (CBN) and cannabidiol (CBD), were given to volunteers. The combination of THC with CBN produced no detectable changes in the quality, intensity, or duration of the effects of THC alone. The THC-CBD combination tended to delay onset and prolong effects of THC, while making them somewhat more intense. Even this interactive effect was slight, providing no reason to abandon the current practice of basing doses of marihuana for clinical studies solely on THC content.

Citing Articles

The Development of Cannabinoids as Therapeutic Agents in the United States.

Murray C, Gannon B, Winsauer P, Cooper Z, Delatte M Pharmacol Rev. 2024; 76(5):915-955.

PMID: 38849155 PMC: 11331953. DOI: 10.1124/pharmrev.123.001121.

Stella N Neuron. 2023; 111(3):302-327.

PMID: 36638804 PMC: 9898277. DOI: 10.1016/j.neuron.2022.12.022.

The effects of subacute exposure to a water-soluble cannabinol compound in male mice.

Bailey M, Emily Mills M, Haas A, Bailey K, Kaufmann R J Cannabis Res. 2022; 4(1):44.

PMID: 35897117 PMC: 9327251. DOI: 10.1186/s42238-022-00153-w.

Cannabinol and Sleep: Separating Fact from Fiction.

Corroon J Cannabis Cannabinoid Res. 2021; 6(5):366-371.

PMID: 34468204 PMC: 8612407. DOI: 10.1089/can.2021.0006.

Safety and tolerability of escalating cannabinoid doses in healthy cats.

Kulpa J, Paulionis L, Eglit G, Vaughn D J Feline Med Surg. 2021; 23(12):1162-1175.

PMID: 33769105 PMC: 8637357. DOI: 10.1177/1098612X211004215.